These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 11834247

  • 1. Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus.
    Gur E, Dremencov E, Van De Kar LD, Lerer B, Newman ME.
    Eur J Pharmacol; 2002 Feb 01; 436(1-2):57-65. PubMed ID: 11834247
    [Abstract] [Full Text] [Related]

  • 2. Chronic clomipramine alters presynaptic 5-HT(1B) and postsynaptic 5-HT(1A) receptor sensitivity in rat hypothalamus and hippocampus, respectively.
    Newman ME, Gur E, Dremencov E, Garcia F, Lerer B, Van de Kar LD.
    Neuropharmacology; 2000 Sep 01; 39(12):2309-17. PubMed ID: 10974314
    [Abstract] [Full Text] [Related]

  • 3. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus.
    Gur E, Dremencov E, Garcia F, Van de Kar LD, Lerer B, Newman ME.
    Brain Res; 2002 Oct 11; 952(1):52-60. PubMed ID: 12363404
    [Abstract] [Full Text] [Related]

  • 4. Functional effects of corticosterone on 5-HT(1A) and 5-HT(1B) receptor activity in rat brain: in vivo microdialysis studies.
    Gur E, Dremencov E, Lerer B, Newman ME.
    Eur J Pharmacol; 2001 Jan 05; 411(1-2):115-122. PubMed ID: 11137865
    [Abstract] [Full Text] [Related]

  • 5. Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo.
    Gur E, Dremencov E, Lerer B, Newman ME.
    Eur J Pharmacol; 1999 May 07; 372(1):17-24. PubMed ID: 10374710
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J, De Montigny C, Blier P.
    Synapse; 1999 Dec 15; 34(4):277-89. PubMed ID: 10529722
    [Abstract] [Full Text] [Related]

  • 10. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
    D'Souza DN, Zhang Y, Garcia F, Battaglia G, Van De Kar LD.
    Psychopharmacology (Berl); 2002 Dec 15; 164(4):392-400. PubMed ID: 12457269
    [Abstract] [Full Text] [Related]

  • 11. Effects of triiodothyronine on 5-HT(1A) and 5-HT(1B) autoreceptor activity, and postsynaptic 5-HT(1A) receptor activity, in rat hypothalamus: lack of interaction with imipramine.
    Gur E, Lifschytz T, Van De Kar LD, Lerer B, Newman ME.
    Psychoneuroendocrinology; 2004 Oct 15; 29(9):1172-83. PubMed ID: 15219641
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo.
    Yoshitake T, Yoshitake S, Yamaguchi M, Ogren SO, Kehr J.
    Neuropharmacology; 2003 Feb 15; 44(2):206-13. PubMed ID: 12623219
    [Abstract] [Full Text] [Related]

  • 14. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
    Béïque J, de Montigny C, Blier P, Debonnel G.
    Neuropharmacology; 2000 Jul 24; 39(10):1813-22. PubMed ID: 10884562
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
    Serres F, Muma NA, Raap DK, Garcia F, Battaglia G, Van de Kar LD.
    J Pharmacol Exp Ther; 2000 Jul 24; 294(1):296-301. PubMed ID: 10871325
    [Abstract] [Full Text] [Related]

  • 17. Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo.
    Rollema H, Clarke T, Sprouse JS, Schulz DW.
    J Neurochem; 1996 Nov 24; 67(5):2204-7. PubMed ID: 8863532
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I.
    J Pharmacol Exp Ther; 2002 Sep 24; 302(3):1220-7. PubMed ID: 12183683
    [Abstract] [Full Text] [Related]

  • 20. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E, Li H, Carr KD, Hiller JM.
    J Pharmacol Exp Ther; 2000 Feb 24; 292(2):684-91. PubMed ID: 10640306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.